Previous 10 | Next 10 |
Increased 2021 revenue guidance projects 54% annual revenue growth at the midpoint of the range 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the...
Company appoints six new members to SAB to maximize the company’s impact in the proteomics domain 908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the forthcoming ...
Channel expansion creates momentum for growth of handheld and desktop products internationally 908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the expansion of its channe...
Global biotherapeutics company transforms mAb characterization and process development with 908 Devices’ point-of-need technologies 908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis,...
BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednes...
Integration of Sartorius SIMCA and Securecell Lucullus PIMS with REBEL Spent Media Analyzer Allows for Data-Driven Decisions and Real-time Value Extraction 908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomo...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The big event next week could be the two-day FOMC meeting that will conclude with a policy statement and Jerome Powell p...
Third Board appointment of 2021 supports long-term vision for the company’s technology platform 908 Devices (NASDAQ: MASS), a pioneer of purpose-built, handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Marcia Eise...
BOSTON, May 20, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate virtually in the upcoming William Blair 41 st Annual Growth Stock ...
908 Devices Inc. (MASS) Q1 2021 Earnings Conference Call May 13, 2021, 08:30 AM ET Company Participants Carrie Mendivil - IR Kevin Knopp - CEO and Co-Founder Joe Griffith - CFO Conference Call Participants Doug Schenkel - Cowen Puneet Souda - SVB Leerink Daniel Arias - Stifel Brian Weinstein ...
News, Short Squeeze, Breakout and More Instantly...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms....
Updated technology enables first responders to identify and quantify approximately 5,000 substances in mere seconds for a swift and definitive response 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an ...
2024-06-01 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...